195 related articles for article (PubMed ID: 32631924)
1. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease.
Teipel SJ; Fritz HC; Grothe MJ;
Neurology; 2020 Sep; 95(10):e1301-e1311. PubMed ID: 32631924
[TBL] [Abstract][Full Text] [Related]
2. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
4. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
5. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.
Grothe MJ; Ewers M; Krause B; Heinsen H; Teipel SJ;
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S344-53. PubMed ID: 24418052
[TBL] [Abstract][Full Text] [Related]
6. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
7. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration.
Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC
Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584
[TBL] [Abstract][Full Text] [Related]
8. Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.
Cantero JL; Atienza M; Lage C; Zaborszky L; Vilaplana E; Lopez-Garcia S; Pozueta A; Rodriguez-Rodriguez E; Blesa R; Alcolea D; Lleo A; Sanchez-Juan P; Fortea J;
Cereb Cortex; 2020 Apr; 30(4):2083-2098. PubMed ID: 31799623
[TBL] [Abstract][Full Text] [Related]
9. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.
Kilimann I; Grothe M; Heinsen H; Alho EJ; Grinberg L; Amaro E; Dos Santos GA; da Silva RE; Mitchell AJ; Frisoni GB; Bokde AL; Fellgiebel A; Filippi M; Hampel H; Klöppel S; Teipel SJ
J Alzheimers Dis; 2014; 40(3):687-700. PubMed ID: 24503619
[TBL] [Abstract][Full Text] [Related]
10. The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model.
Zhou XA; Ngiam G; Qian L; Sankorrakul K; Coulson EJ; Chuang KH
Neurobiol Aging; 2022 Sep; 117():24-32. PubMed ID: 35640461
[TBL] [Abstract][Full Text] [Related]
11. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.
Dawe RJ; Bennett DA; Schneider JA; Arfanakis K
PLoS One; 2011; 6(10):e26286. PubMed ID: 22043314
[TBL] [Abstract][Full Text] [Related]
12. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome.
Rozalem Aranha M; Iulita MF; Montal V; Pegueroles J; Bejanin A; Vaqué-Alcázar L; Grothe MJ; Carmona-Iragui M; Videla L; Benejam B; Arranz J; Padilla C; Valldeneu S; Barroeta I; Altuna M; Fernández S; Ribas L; Valle-Tamayo N; Alcolea D; González-Ortiz S; Bargalló N; Zetterberg H; Blennow K; Blesa R; Wisniewski T; Busciglio J; Cuello AC; Lleó A; Fortea J
Alzheimers Dement; 2023 Nov; 19(11):4817-4827. PubMed ID: 37021589
[TBL] [Abstract][Full Text] [Related]
13. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
14. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.
Grothe MJ; Schuster C; Bauer F; Heinsen H; Prudlo J; Teipel SJ
J Neurol; 2014 Oct; 261(10):1939-48. PubMed ID: 25059393
[TBL] [Abstract][Full Text] [Related]
15. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
[TBL] [Abstract][Full Text] [Related]
16. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.
Ohm DT; Fought AJ; Rademaker A; Kim G; Sridhar J; Coventry C; Gefen T; Weintraub S; Bigio E; Mesulam MM; Rogalski E; Geula C
Brain Pathol; 2020 Mar; 30(2):332-344. PubMed ID: 31446630
[TBL] [Abstract][Full Text] [Related]
18. Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.
Dallaire-Théroux C; Callahan BL; Potvin O; Saikali S; Duchesne S
J Alzheimers Dis; 2017; 57(2):575-601. PubMed ID: 28282807
[TBL] [Abstract][Full Text] [Related]
19. Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia.
Teipel S; Raiser T; Riedl L; Riederer I; Schroeter ML; Bisenius S; Schneider A; Kornhuber J; Fliessbach K; Spottke A; Grothe MJ; Prudlo J; Kassubek J; Ludolph A; Landwehrmeyer B; Straub S; Otto M; Danek A;
Cortex; 2016 Oct; 83():124-35. PubMed ID: 27509365
[TBL] [Abstract][Full Text] [Related]
20. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease.
Cavedo E; Grothe MJ; Colliot O; Lista S; Chupin M; Dormont D; Houot M; Lehéricy S; Teipel S; Dubois B; Hampel H;
Sci Rep; 2017 Sep; 7(1):11706. PubMed ID: 28916821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
